1482 Results for
- View:
- Only Recruiting Trials
-
All Trials
| Study Title | Principal Investigator |
|---|---|
|
A Phase 2, Open-label, Translational Biology Study of Momelotinib in Transfusion-Dependent Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)
Not recruiting | | Multisite
|
|
|
A Randomized, Open-Label, Phase 3 Study of Nivolumab (BMS-936558) vs. Everolimus in Subjects With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
Not recruiting | Kidney Cancer | Multisite
|
|
Powered by
SC CTSI